Preparing for FDA Inspections of Devices & Combination Products

Duration: 60 Minutes
This training explores how to prepare for an FDA inspection of a combination product or device. Combination products are defined along with a brief explanation of the Primary Mode of Action. The QSR and GMP regulations are discussed in reference to combination products. Inspection agendas and examples are given. What is emphasized during the inspection vs. what is in the application is discussed. How to avoid common pitfalls with combination products and strategies for a successful approval inspection are discussed. Know key behaviors for a successful combination product or device inspection.
FDA Inspections of Devices & Combination Products
Instructor: Kenneth F. Miles
Product ID: 503900
Objectives of the Presentation
  • How to prepare for an FDA inspection
  • What to expect when FDA shows up
  • Inspectional Strategy
  • QSR and GMPs
  • Demonstrating Compliance
  • How to respond to an FDA 483
Why should you Attend
Good Manufacturing Practice (CGMP) requirements for combination products that FDA issued on January 22, 2013 (final rule) (21 Code of Federal Regulations (CFR) part 4). Prior to issuance of the final rule, although CGMP regulations were in place to establish requirements for drugs, devices, biological products, and Human Cells, Tissues, and Cellular and Tissue-Based Products (HCT/Ps), there were no regulations to clarify and explain the application of these CGMP requirements to combination products. The final rule did not establish any new requirements; it was intended to clarify which CGMP requirements apply when drugs, devices and biological products are combined to create combination products, and to set forth a transparent and streamlined regulatory framework for firms to use when demonstrating compliance with applicable CGMP requirements.

Areas Covered
  • Introduction
  • Background
  • Consideration for CGMP Compliance
  • CGMP Requirements Specified 21 CFR 4.4(b)
  • QSR and CGMP
  • How to respond to an FDA 483
Who will Benefit
  • Regulatory Affairs Managers & Personnel
  • Quality Assurance Managers & Personnel
  • Compliance Managers
  • Specialist & Personnel
  • Project Managers
  • Risk Managers
  • Complaint Handling Teams
Topic Background
The final rule did not establish any new requirements; it was intended to clarify which CGMP requirements apply when drugs, devices, and biological products are combined to create combination products, and to set forth a transparent and streamlined regulatory framework for firms to use when demonstrating compliance with applicable CGMP requirements.
$375
Recorded Session for one participant
Get life time access with download option!
Book This Course
  $500.00 Training CD
Free shipment within 4 Days, from the date of webinar completion. Get life time access for unlimited participants.
For multiple location please contact our customer care team +1-510-857-5896.
Do you want to Host
this webinar at your Organization!
Call us at +1-510-857-5896
Email us at webinar@onlinecompliancepanel.com
Minimum 10 attendees
How it works
Live Session - How it works
  • Login to onlinecompliancepanel with your registered username and password https://www.onlinecompliancepanel.com/login
  • The webinar joining link, username and password for joining the webinar will be updated on your OCP Account 24 hours prior to the webinar
  • Presentation handouts in Downloadable PDF format will be updated on your OCP Account 24 hours prior to the live session
  • Login to the audio conference on the scheduled date and time
  • Get answers to your queries through interactive Q&A sessions via chat at the end of the session
  • Download the Certificate of Attendance and Purchase Invoice from your OCP Account 24 hours after the completion of the session
  • Please let us know your thoughts and views at the end of the webinar, your valuable feedback will help us improve
Recorded Session - How it works
  • Login to onlinecompliancepanel with your registered username and password https://www.onlinecompliancepanel.com/login
  • Upon purchase of the recorded session a link will be updated on your OCP Account within 24 hours
  • Please click on the link to access the Recorded Session
  • Presentation handouts in downloadable PDF format will be updated on your OCP Account within 24 hours of the purchase of the product
  • Download the Certificate of Attendance and Purchase Invoice from your OCP Account after 48 hours of the product Purchase
  • Please share your valuable Feedback at the end of the session
Instructor Profile:
Dr. Kenneth F. Miles is a seasoned professional in Quality, Regulatory and Clinical affairs and development strategy for drugs, biologics, medical devices and combination products. He has worked in senior quality and regulatory roles in the medical products industry for more than 20 years. Dr. Miles has worked for a number of large and small pharmaceutical, biotech and medical device companies. He also interfaced with FDA at Local, District and Centre levels and has dealt with several foreign ministries to bring companies into compliance. He has set up regulatory and quality systems for countries around the world, including the Pacific Rim, Europe and South America. He is the senior member of the American Society for Quality, (Certified Quality Engineer) and member and Fellow of Regulatory Affairs Professional Society (Certified Regulatory Affairs). Dr. Kenneth F. Miles is the recipient of the GMP Institute Hall of Fame Award.


View More